Search research articles
Contact Us
Filters
Showing results (11-20 of 169) with videos related to
Page
of 17
Sort By:
Human Pathology
|
March 3, 2020
Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort
Michael C Haffner, Daniela C Salles, Guofeng Gao, et al.
Urology
|
February 14, 2022
Whole Genome Sequencing Reveals Independent Clonal Origin of Bilateral Testicular Germ Cell Tumors in 2 Patients with Pure Seminoma
Michael J Biles, Michael C Haffner, Brian Hanratty, et al.
Human Pathology
|
November 8, 2019
Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer
Turki Al-Hussain, Michael C Haffner, Waleed M Altaweel, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2018
Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells
Naseruddin Höti, Shuang Yang, Yingwei Hu, et al.
Nucleic Acids Research
|
February 14, 2006
Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
Srinivasan Yegnasubramanian, Xiaohui Lin, Michael C Haffner, et al.
Plos One
|
July 26, 2012
Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma
Brent A Orr, Michael C Haffner, William G Nelson, et al.
The American Journal of Surgical Pathology
|
October 1, 2020
Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements
Neil M Neumann, Michael C Haffner, Pedram Argani, et al.
Current Opinion in Urology
|
March 3, 2015
Should Gleason 6 be labeled as cancer?
Ibrahim Kulac, Michael C Haffner, Srinivasan Yegnasubramanian, et al.
Urologic Oncology
|
January 28, 2026
Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer
Ryuta Watanabe, Noriyoshi Miura, Tadahiko Kikugawa, et al.
European Urology
|
August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer
Adam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 169) with videos related to
Sort By:
Page
of 17
Human Pathology
|
March 3, 2020
Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort
Michael C Haffner, Daniela C Salles, Guofeng Gao, et al.
Urology
|
February 14, 2022
Whole Genome Sequencing Reveals Independent Clonal Origin of Bilateral Testicular Germ Cell Tumors in 2 Patients with Pure Seminoma
Michael J Biles, Michael C Haffner, Brian Hanratty, et al.
Human Pathology
|
November 8, 2019
Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer
Turki Al-Hussain, Michael C Haffner, Waleed M Altaweel, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2018
Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells
Naseruddin Höti, Shuang Yang, Yingwei Hu, et al.
Nucleic Acids Research
|
February 14, 2006
Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
Srinivasan Yegnasubramanian, Xiaohui Lin, Michael C Haffner, et al.
Plos One
|
July 26, 2012
Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma
Brent A Orr, Michael C Haffner, William G Nelson, et al.
The American Journal of Surgical Pathology
|
October 1, 2020
Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements
Neil M Neumann, Michael C Haffner, Pedram Argani, et al.
Current Opinion in Urology
|
March 3, 2015
Should Gleason 6 be labeled as cancer?
Ibrahim Kulac, Michael C Haffner, Srinivasan Yegnasubramanian, et al.
Urologic Oncology
|
January 28, 2026
Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer
Ryuta Watanabe, Noriyoshi Miura, Tadahiko Kikugawa, et al.
European Urology
|
August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer
Adam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Page
of 17